Oscar Health posts Q3 profit, lifts full‑year earnings and revenue outlook
Oscar Health reported third‑quarter 2026 revenue of $5.14 billion and net income of $167.3 million, equating to earnings of $0.49 per share. The results beat analysts’ expectations by $0.63 per share. The company raised its full‑year 2026 operating earnings outlook to $850 million‑$950 million and its revenue guidance to $19.0 billion‑$19.3 billion. CEO Mark Bertolini said disciplined pricing and technology‑driven efficiency are driving the stronger economics.
Why it matters
The earnings beat and higher guidance suggest improved profitability and may support a higher valuation, as noted in the company’s press release. The raised outlook also expands the revenue target range for investors tracking Oscar Health’s growth trajectory.
Key facts
- 1Third‑quarter 2026 revenue was $5.14 billion. tradingview.com
- 2Net income attributable to Oscar Health was $167.3 million, or $0.49 per share. sec.gov
- 3Earnings from operations were $178.0 million for the quarter. sec.gov
- 4Adjusted EBITDA for the quarter was $206.9 million. sec.gov
- 5Full‑year 2026 operating earnings outlook was raised to $850 million‑$950 million. sec.gov
- 6Full‑year 2026 revenue guidance was raised to $19.0 billion‑$19.3 billion. sec.gov
Summary written by AlphAI AI Desk from 7 of 7 sources. Not investment advice. Figures are as stated by the linked sources.